Clinical Trial Update: Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial is evaluating granulocyte-macrophage colony-stimulating factor (GM-CSF) for treating Peripheral Artery Disease and is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• Granulocyte-Macrophage Stimulating Factor (GM-CSF) (granulocyte-macrophage colony-stimulating factor)

Snippet

Sponsor: Emory University | Conditions: Peripheral Artery Disease (PAD) | Phase 2 | Status: RECRUITING